To investigate whether miR-30c-1-3p and miR-30c-2-3p bound directly to the 3′ UTR of TRIP13 in BrCa cells, dual-luciferase reporter assays were conducted (Figure 9A). Here, TRIP13 is linked to invasive breast carcinoma.